Scientific article

Upregulation of CD40, CD80, CD83 or CD86 on alveolar macrophages after lung transplantation

Published inThe Journal of heart and lung transplantation, vol. 24, no. 8, p. 1067-1075
Publication date2005

Alveolar macrophages (AMs) are known to be poor antigen-presenting cells, and lack the accessory molecules such as CD40, CD80 or CD86 to activate T cells. The question raised is about the potential changes in phenotypes after lung transplantation, particularly during acute rejection episodes.

  • Adult
  • Aged
  • Antigens, CD/analysis
  • Antigens, CD40/analysis
  • Antigens, CD86/analysis
  • Biological Markers/analysis
  • Bronchoalveolar Lavage Fluid/cytology
  • Case-Control Studies
  • Female
  • Flow Cytometry
  • Graft Rejection
  • Graft Survival
  • Humans
  • Immunoglobulins/analysis
  • Immunohistochemistry
  • Lung Transplantation/adverse effects/immunology
  • Macrophages, Alveolar/cytology
  • Male
  • Membrane Glycoproteins/analysis
  • Middle Aged
  • Prognosis
  • Reference Values
  • Retrospective Studies
  • Sensitivity and Specificity
  • Transplantation Immunology/physiology
  • Up-Regulation
Citation (ISO format)
NICOD, Laurent et al. Upregulation of CD40, CD80, CD83 or CD86 on alveolar macrophages after lung transplantation. In: The Journal of heart and lung transplantation, 2005, vol. 24, n° 8, p. 1067–1075. doi: 10.1016/j.healun.2004.07.011
Main files (1)
Article (Published version)
ISSN of the journal1053-2498

Technical informations

Creation09/04/2014 12:36:00 PM
First validation09/04/2014 12:36:00 PM
Update time03/14/2023 9:34:50 PM
Status update03/14/2023 9:34:50 PM
Last indexation01/16/2024 11:46:36 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack